Clorox (CLX) FY2012 results: revenue $5.4 billion, up 2.8% on the year
Clorox Co. (CLX) reported revenue of $5.4 billion for fiscal 2012, the year ended 30 June 2012, up 2.8% on the year before. Net income was $541 million, down 2.9%, and diluted earnings per share $4.09. The figures are the company's own, from the 10-K it filed with the SEC on 23 August 2013.
Revenue
$5.4 billion
+2.8% on the year
FY2008FY2012
Operating margin
n/a
FY2008FY2012
Net income
$541 million
-2.9% on the year
FY2008FY2012
Diluted EPS
$4.09
+1.7% on the year
FY2008FY2012
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Revenue
5,379
5,231
5,234
+2.8%
Cost of revenue
3,107
2,958
2,915
+5.0%
Gross profit
2,272
2,273
2,319
-0.0%
Gross margin
42.2%
43.5%
44.3%
Research and development
121
115
118
+5.2%
Selling, general and administrative
783
735
734
+6.5%
Interest expense
125
123
139
+1.6%
Income tax
243
276
322
-12.0%
Net income
541
557
603
-2.9%
Net margin
10.1%
10.6%
11.5%
Diluted EPS
$4.09
$4.02
$4.24
+1.7%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Operating cash flow
612
698
819
-12.3%
Capital expenditure
189
228
201
-17.1%
Free cash flow
423
470
618
-10.0%
Free cash flow margin
7.9%
9.0%
11.8%
Cash from investing
-277
544
-231
Cash from financing
-321
-1,078
-706
Depreciation and amortisation
178
173
183
+2.9%
Share-based compensation
27.0
32.0
60.0
-15.6%
Buybacks
225
655
150
-65.6%
Dividends paid
315
303
282
+4.0%
Dividend per share
$2.44
$2.25
$2.05
+8.4%
Diluted shares, weighted
132m
138m
142m
-4.2%
Shares outstanding at period end
130m
131m
139m
-1.1%
Balance sheet
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Shareholders' equity
-135
-86.0
83.0
Debt
2,721
2,584
2,795
+5.3%
Other liabilities
1,769
1,665
1,677
+6.2%
Total liabilities and equity
4,355
4,163
4,555
+4.6%
Fixed assets
1,081
1,039
966
+4.0%
Goodwill
1,112
1,070
1,303
+3.9%
Cash and equivalents
267
259
87.0
+3.1%
Receivables
576
525
540
+9.7%
Inventory
384
382
332
+0.5%
Other assets
935
888
1,327
+5.3%
Total assets
4,355
4,163
4,555
+4.6%
10-K for the year ended 30 June 2012, filed 23 August 2013: the filing.